>
pdufa.bio

deucrictibant

Updated ยทnext FDA decision on the calendar

deucrictibant is a Pharvaris N.V. program. Its next catalyst is a Readout in Q3 2026. Every date links its source.

PHVS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Pharvaris N.V. (PHVS). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026PHVS

Questions

When is deucrictibant's next FDA decision or readout?

The next tracked catalyst for deucrictibant is a Readout in Q3 2026.

What happened at deucrictibant's most recent FDA decision?

No FDA decision for deucrictibant is in our archive yet.

Who makes deucrictibant?

Pharvaris N.V. (PHVS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.